Observe Medical ASA: Mandatory notification of trade by primary insider and disclosure of shareholding
Observe Medical ASA (OBSRV) · publisert 12. desember 2024 kl. 20:00 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Rune Christian Nystad via UX Holding AS | – | Kjøp | 1 144 962 | 0,4 NOK | 11. desember 2024 | NO0010865009 | XOAS - Euronext Expand Oslo |
| Rune Christian Nystad | Chief Development Officer (CDO) in Observe Medical ASA | Annet Uklassifisert | 1 144 962 | 0,4 NOK | 11. desember 2024 | NO0010865009 | XOAS - Euronext Expand Oslo 2 |
Vedlegg
- OMASA_Notification_of_transaction_Rune_Nystad_and_UX_Holding_AS.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, 12 December 2024: Observe Medical ASA (the "Company") has been informed
that Rune Nystad, CDO and primary insider in the Company, has sold
1,144,962 shares in the Company to his wholly owned investment company US
Holding AS as part of a reorganization of his shareholding.
Following this, 1,662,483 of the shares in Observe Medical ASA is still
controlled by Rune Nystad.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.